Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2026
Time of day of neoadjuvant immune checkpoint inhibitor administration is associated with survival but not pathological response in resectable stage III-IV melanoma: A retrospective cohort studyAxel Nelson, Safa Alghaib, Karl Björkström, et al.Journal for Immunotherapy of Cancer|March 18, 2026
Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial)Axel Nelson, Rebecca Riise, Samuel Alsén, et al.Journal of the National Cancer Institute|July 10, 2026
Neoadjuvant immunotherapy for resectable cutaneous melanoma: a nationwide population-based cohortAxel Nelson, Ellen Krabbe, Karl Björkström, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2023
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, et al.Annals of Surgery|February 29, 2024
Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUMRoger Olofsson Bagge, Axel Nelson, Amir Shafazand, et al.Pageof 2